Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ga-68-FAPI-46 PET in Recurrent Colorectal Cancer
NCT06769828Recruiting
- Sponsor
- Koo Foundation Sun Yat-Sen Cancer Center
- Start
- Feb 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Koo Foundation Sun Yat-Sen Cancer Center. Primary endpoints: Sensitivity, Specificity, and Accuracy of Ga-68-FAPI-46 PET for CRC Recurrence Detection at 6 months and Comparison of Ga-68-FAPI-46 PET and FDG PET in CRC Recurrence Detection at 6 months. Started Feb 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06769828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06769828.